Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Co-Diagnostics Inc (CODX) USD0.001

Sell:$1.05 Buy:$1.39 Change: $0.06 (5.36%)
NASDAQ:0.80%
Market closed |  Prices as at close on 20 September 2019 | Switch to live prices |
Sell:$1.05
Buy:$1.39
Change: $0.06 (5.36%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed |  Prices as at close on 20 September 2019 | Switch to live prices |
Sell:$1.05
Buy:$1.39
Change: $0.06 (5.36%)
Market closed |  Prices as at close on 20 September 2019 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Contact details

Address:
4049 S Highland Dr
SALT LAKE CITY
84124-1664
United States
Telephone:
+1 (801) 2789769
Website:
codiagnostics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CODX
ISIN:
US1897631057
Market cap:
$18.15 million
Shares in issue:
17.12 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Dwight Egan
    Chairman of the Board, President, Chief Executive Officer
  • Reed Benson
    Chief Financial Officer, Secretary
  • Brent Satterfield
    Chief Scientific Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.